Journal article

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

Katrina Williams, Amanda Brignell, Melinda Randall, Natalie Silove, Philip Hazell

Cochrane Database of Systematic Reviews | WILEY | Published : 2013

DOI: 10.1002/14651858.CD004677.pub3

Grants

Funding Acknowledgements

Internal sourcesSmall Grants Scheme, The Children's Hospital at Westmead, Sydney, Australia.External sourcesFinancial Markets Foundation for Children, Australia.Department of Health and Aging, Australia.Cochrane Entities funding

Citation metrics

39Web of Science
212Scopus

Keywords

Fluoxetine [therapeutic Use]
Serotonin Uptake Inhibitors
Autistic Disorder
Fenfluramine
Citalopram
Autistic Disorder [drug Therapy; Psychology]
Obsessive-Compulsive Scale
Medication Use
Placebo
Obsessive-Compulsive Disorder [drug Therapy]
Fluoxetine
Fluvoxamine [therapeutic Use]
Child Development Disorders, Pervasive
Medicine, General & Internal
Humans
Adult
Age Factors
Citalopram [therapeutic Use]
Fenfluramine [therapeutic Use]
Clomipramine
Children
Life Sciences & Biomedicine
General & Internal Medicine
Double-Blind
Science & Technology
Randomized Controlled Trials As Topic
Serotonin Uptake Inhibitors [therapeutic Use]
Repetitive Behaviors
Obsessive-Compulsive Disorder
Child
Fluvoxamine